胜肽合成市场规模、份额和成长分析（按产品/服务、技术、最终用户和地区划分）—产业预测（2026-2033 年）

预计到 2024 年，胜肽合成市场规模将达到 7.9112 亿美元，到 2025 年将成长至 8.9397 亿美元，到 2033 年将成长至 23.7657 亿美元，在预测期（2026-2033 年）内复合年增长率为 13%。

受肽类药物日益增长的需求推动，肽合成市场正经历显着增长。这些药物以其作为信号分子靶向细胞膜上特定受体并触发重要细胞内反应的能力而闻名。与小分子药物和生技药品相比，这些药物具有代谢稳定性、特异性和更高的结合亲和性等优势。这种独特性对药理学研究、分析方法开发和杂质分析都具有重要意义。胜肽合成需求的激增部分归因于基于胜肽的诊断和治疗方案的核准不断增加。此外，目前正在进行大量临床试验，以评估胜肽在治疗各种慢性疾病方面的疗效，这将进一步加速市场成长。

肽合成市场驱动因素

对慢性疾病精准诊断日益增长的需求，显着推动了成像技术需求的成长，进而促进了胜肽合成市场的发展，使其估值显着提升。生物感测器和生物标记在侵入性和非侵入性诊断方法中的应用日益普及。这一趋势在对基于胜肽的生物感测器和生物标记的需求增长上尤为明显，并推动了肽合成领域的重大进步。随着医疗保健环境的不断发展，对开发高效创新诊断工具的重视，进一步促进了该细分市场的成长。

肽合成市场限制因素

肽合成市场面临的主要限制因素是製药公司依赖契约製造製造商生产肽类药物。这些契约製造主要位于生产成本较低的已开发国家。然而，这种依赖性会带来挑战，因为每家公司都必须遵守各种标准化和安全准则，这可能会影响整个生产过程的效率和品质。此外，严格的监管要求可能会限制胜肽生产的柔软性和可扩展性，从而在肽类药物需求不断增长的情况下阻碍市场成长。

胜肽合成市场趋势

受製药业蓬勃发展的推动，肽合成市场正经历显着成长。研发投入的增加带动了新型态疗法研发领域的投资成长。随着製药公司寻求创新解决方案以满足尚未满足的医疗需求，对胜肽类药物的需求激增，进而推动了对先进胜肽合成技术的投资。慢性病盛行率的上升和对个人化医疗日益增长的关注进一步强化了这一趋势，凸显了量身定制治疗方案的必要性。这些因素共同为胜肽合成解决方案创造了强劲的市场环境，使其有望持续扩张。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 一手和二手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• 用例分析

全球胜肽合成市场规模（依产品/服务划分）及复合年增长率（2026-2033 年）

• 试剂
  • 树脂
  • 胺基酸
  • 耦合试剂
  • 染料和萤光标记试剂
  • 其他试剂
• 装置
  • 胜肽合成仪
  • 层析法设备
  • 冷冻干燥机
• 服务

全球胜肽合成市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 固相胜肽合成
• 溶液相胜肽合成
• 混合重组技术

全球胜肽合成市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 製药和生物技术公司
• CDMO 和 CRO
• 学术和研究机构

全球胜肽合成市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • GCC
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

  主要企业简介

  • MERCK KGAA
  • THERMO FISHER SCIENTIFIC
  • GENSCRIPT BIOTECH CORPORATION
  • BACHEM HOLDING AG
  • KANEKA CORPORATION
  • BIOTAGE AB
  • SYNGENE INTERNATIONAL LIMITED
  • MESA LABORATORIES, INC.
  • CEM CORPORATION
  • PROTEOGENIX
  • BIO-SYNTHESIS INC.
  • DALTON PHARMA SERVICES
  • AAPPTEC
  • VIVITIDE
  • ANYGEN CO., LTD.
  • ADVANCED CHEMTECH
  • LUXEMBOURG BIO TECHNOLOGIES LTD.
  • JPT PEPTIDE TECHNOLOGIES GMBH
  • AMBIOPHARM INC.
  • AURIGENE PHARMACEUTICAL SERVICES LTD.

结论与建议

Peptide Synthesis Market size was valued at USD 791.12 Million in 2024 and is poised to grow from USD 893.97 Million in 2025 to USD 2376.57 Million by 2033, growing at a CAGR of 13% during the forecast period (2026-2033).

The peptide synthesis market is witnessing significant growth fueled by the increasing interest in peptide-based therapeutics, which are recognized for their ability to act as signaling molecules that target specific receptors on cell membranes, triggering crucial intracellular responses. These therapeutic agents offer advantages such as improved metabolic stability, specificity, and binding affinity compared to small molecule drugs and biologics. This distinctiveness influences their pharmacological research, analytical development, and impurity analysis. A surge in demand for peptide synthesis is evident, partly due to an uptick in approvals for peptide-based diagnostic and therapeutic solutions. Additionally, the landscape is marked by a considerable number of ongoing clinical trials focused on evaluating the efficacy of peptides in treating various chronic conditions, enhancing the market's growth trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peptide Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peptide Synthesis Market Segments Analysis

Global Peptide Synthesis Market is segmented by Product & Services, Technology, end user and region. Based on Product & Services, the market is segmented into Reagents, Equipment, Services. Based on Technology, the market is segmented into Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid & Recombinant Technology. Based on end user, the market is segmented into Pharmaceutical & Biotechnology companies, CDMOs & CROs, Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Peptide Synthesis Market

The demand for imaging technologies is significantly increasing due to the need for precise diagnosis of chronic diseases, contributing to the growth of the peptide synthesis market, which has achieved notable financial valuation. The utilization of biosensors and biomarkers for both invasive and non-invasive diagnostic methods is becoming increasingly common. This trend is particularly evident in the rising demand for peptide-based biosensors and biomarkers, which is driving substantial advancements within the peptide synthesis sector. As the healthcare landscape evolves, the emphasis on developing efficient and innovative diagnostic tools is further propelling growth in this market segment.

Restraints in the Peptide Synthesis Market

The peptide synthesis market faces constraints primarily due to the reliance of pharmaceutical companies on contract manufacturing firms for the production of peptide-based therapeutic products. These contract manufacturers are mainly located in developed economies, where production costs are lower. However, this dependency can lead to challenges, as these firms must navigate various standardization and safety guidelines, which can affect the overall efficiency and quality of the manufacturing process. Additionally, the need for compliance with stringent regulations may limit the flexibility and scalability of peptide production, potentially hindering the growth of the market as demand for peptide therapies increases.

Market Trends of the Peptide Synthesis Market

The peptide synthesis market is experiencing significant growth driven by the expanding pharmaceutical industry, where escalating R&D expenditures are increasingly allocated to the development of novel therapeutic agents. As pharmaceutical companies seek innovative solutions to address unmet medical needs, the demand for peptide-based drugs is surging, leading to heightened investment in advanced peptide synthesis technologies. This trend is further fueled by the rising prevalence of chronic diseases and the growing emphasis on personalized medicine, which underscores the need for tailored therapeutic approaches. The convergence of these factors is creating a robust landscape for peptide synthesis solutions, positioning the market for sustained expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis

Global Peptide Synthesis Market Size by Product & Service & CAGR (2026-2033)

• Reagents
  • Resins
  • Amino acids
  • Coupling Reagents
  • Dyes and Fluorescent labeling reagents
  • Other Reagents
• Equipment
  • Peptide Synthesizers
  • Chromatography Equipment
  • Lyophiizers
• Services

Global Peptide Synthesis Market Size by Technology & CAGR (2026-2033)

• Solid-Phase Peptide Synthesis
• Solution-Phase Peptide Synthesis
• Hybrid & Recombinant Technology

Global Peptide Synthesis Market Size by End User & CAGR (2026-2033)

• Pharmaceutical & Biotechnology companies
• CDMOs & CROs
• Academic & Research Institutes

Global Peptide Synthesis Market Size & CAGR (2026-2033)

• North America, (Product & Services, Technology, End User)
  • US
  • Canada
• Europe, (Product & Services, Technology, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product & Services, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product & Services, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product & Services, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• MERCK KGAA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• THERMO FISHER SCIENTIFIC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GENSCRIPT BIOTECH CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BACHEM HOLDING AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KANEKA CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTAGE AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SYNGENE INTERNATIONAL LIMITED
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MESA LABORATORIES, INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CEM CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PROTEOGENIX
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIO-SYNTHESIS INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DALTON PHARMA SERVICES
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AAPPTEC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VIVITIDE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANYGEN CO., LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADVANCED CHEMTECH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LUXEMBOURG BIO TECHNOLOGIES LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JPT PEPTIDE TECHNOLOGIES GMBH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMBIOPHARM INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AURIGENE PHARMACEUTICAL SERVICES LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation